Search research articles
Contact Us
Filters
Showing results (31-40 of 55) with videos related to
Page
of 6
Sort By:
Plos One
|
May 1, 2012
Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study
Inger Vedin, Tommy Cederholm, Yvonne Freund-Levi, et al.
The American Journal of Clinical Nutrition
|
June 11, 2008
Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study
Inger Vedin, Tommy Cederholm, Yvonne Freund Levi, et al.
Archives of Neurology
|
October 13, 2006
Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial
Yvonne Freund-Levi, Maria Eriksdotter-Jönhagen, Tommy Cederholm, et al.
International Journal of Geriatric Psychiatry
|
June 22, 2007
Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms
Yvonne Freund-Levi, Hans Basun, Tommy Cederholm, et al.
Journal of Lipid Research
|
December 8, 2009
Reduced prostaglandin F2 alpha release from blood mononuclear leukocytes after oral supplementation of omega3 fatty acids: the OmegAD study
Inger Vedin, Tommy Cederholm, Yvonne Freund-Levi, et al.
Journal of Alzheimer'S Disease : JAD
|
November 21, 2017
Does Fatty Acid Composition in Subcutaneous Adipose Tissue Differ between Patients with Alzheimer's Disease and Cohabiting Proxies?
Gerd Faxen-Irving, Farshad Falahati, Hans Basun, et al.
Archives of Neurology
|
April 17, 2008
Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer disease
Hans Basun, Nenad Bogdanovic, Martin Ingelsson, et al.
The American Journal of Clinical Nutrition
|
September 1, 2017
DHA-rich n-3 fatty acid supplementation decreases DNA methylation in blood leukocytes: the OmegAD study
Mohsen Karimi, Inger Vedin, Yvonne Freund Levi, et al.
Journal of Alzheimer'S Disease : JAD
|
September 25, 2015
Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study
Maria Eriksdotter, Inger Vedin, Farshad Falahati, et al.
Journal of Alzheimer'S Disease : JAD
|
August 15, 2012
Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementia
Bob Olsson, Joakim Hertze, Ronald Lautner, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 55) with videos related to
Sort By:
Page
of 6
Plos One
|
May 1, 2012
Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study
Inger Vedin, Tommy Cederholm, Yvonne Freund-Levi, et al.
The American Journal of Clinical Nutrition
|
June 11, 2008
Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study
Inger Vedin, Tommy Cederholm, Yvonne Freund Levi, et al.
Archives of Neurology
|
October 13, 2006
Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial
Yvonne Freund-Levi, Maria Eriksdotter-Jönhagen, Tommy Cederholm, et al.
International Journal of Geriatric Psychiatry
|
June 22, 2007
Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms
Yvonne Freund-Levi, Hans Basun, Tommy Cederholm, et al.
Journal of Lipid Research
|
December 8, 2009
Reduced prostaglandin F2 alpha release from blood mononuclear leukocytes after oral supplementation of omega3 fatty acids: the OmegAD study
Inger Vedin, Tommy Cederholm, Yvonne Freund-Levi, et al.
Journal of Alzheimer'S Disease : JAD
|
November 21, 2017
Does Fatty Acid Composition in Subcutaneous Adipose Tissue Differ between Patients with Alzheimer's Disease and Cohabiting Proxies?
Gerd Faxen-Irving, Farshad Falahati, Hans Basun, et al.
Archives of Neurology
|
April 17, 2008
Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer disease
Hans Basun, Nenad Bogdanovic, Martin Ingelsson, et al.
The American Journal of Clinical Nutrition
|
September 1, 2017
DHA-rich n-3 fatty acid supplementation decreases DNA methylation in blood leukocytes: the OmegAD study
Mohsen Karimi, Inger Vedin, Yvonne Freund Levi, et al.
Journal of Alzheimer'S Disease : JAD
|
September 25, 2015
Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study
Maria Eriksdotter, Inger Vedin, Farshad Falahati, et al.
Journal of Alzheimer'S Disease : JAD
|
August 15, 2012
Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementia
Bob Olsson, Joakim Hertze, Ronald Lautner, et al.
Page
of 6